Gonadorelin vs. HCG on TRT: Which Is Better for Testicular Health?

One of the most common concerns men have about starting testosterone replacement therapy is testicular atrophy — the shrinkage of the testes that occurs when exogenous testosterone suppresses the body’s natural LH signal to the testes. This concern is valid, and addressing it proactively is part of a well-designed TRT protocol. Two primary options exist: HCG and gonadorelin.

How the Testes Signal Works

Normally, the pituitary releases LH (luteinizing hormone), which tells the Leydig cells in the testes to produce testosterone and maintain testicular volume. On TRT, elevated blood testosterone tells the pituitary to stop producing LH — so the testes receive no signal, reduce activity, and gradually shrink. This shrinkage is primarily a reduction in volume, not permanent damage, and is reversible in most cases — but many men find it aesthetically and psychologically distressing.

HCG: The Proven Standard

HCG (human chorionic gonadotropin) is a hormone that mimics LH by binding to the same receptor on Leydig cells. It directly stimulates testicular testosterone production and maintains testicular size and function even while exogenous testosterone suppresses the pituitary’s LH output. HCG has decades of clinical use in TRT protocols and fertility medicine, and its efficacy for testicular preservation is well established. Typical dosing is 250–500 IU, two to three times weekly.

One consideration with HCG is that it stimulates testicular estradiol production alongside testosterone — meaning men who are already prone to high estradiol on TRT may need more careful aromatase management when adding HCG. HCG has also faced supply and compounding regulation challenges in recent years.

Gonadorelin: The Upstream Alternative

Gonadorelin is a synthetic version of GnRH (gonadotropin-releasing hormone), the hypothalamic hormone that normally triggers LH and FSH release from the pituitary. Rather than acting directly on the testes, gonadorelin acts upstream — stimulating the pituitary to release LH and FSH naturally. This approach more closely mimics the body’s physiological signaling cascade and stimulates both testosterone and sperm production.

For men on TRT who want to maintain fertility as well as testicular volume, gonadorelin may offer the advantage of preserving FSH-driven spermatogenesis in addition to LH-driven testosterone production. The typical protocol involves subcutaneous injections two to three times weekly. At Multigen Wellness, we individualize the choice between HCG and gonadorelin based on patient goals, availability, and response. Call +1 (800) 259-0015 to discuss the best approach for your protocol.